1. Introduction {#sec1}
===============

Exfoliation syndrome (XFS) is an age-related, systemic, elastic microfibrillopathy characterized by deposition and progressive accumulation of a white, fibrillary, extracellular material affecting intraocular and extraocular tissues \[[@B1]\]. A recent study has suggested a high prevalence of XFS in the Uygur population \[[@B2], [@B3]\]. XFS is characterized by rapid progression, high resistance to medical therapy, and poor prognosis and may lead to exfoliation glaucoma (XFG), open-angle glaucoma, angle-closure glaucoma, and acceleration of cataract insensibly \[[@B4]\]. In China, especially in Xinjiang, many XFS/XFG patients lost their visual acuity due to the lack of medical treatment.

Genetic factors have an important role in XFS pathogenesis. Our previous data have suggested that three single-nucleotide polymorphisms (SNPs), i.e.,rs1048661, rs3825942, and rs2165241, of the lysyl oxidase-like 1 gene (*LOXL1*) were significantly associated with XFS and XFG \[[@B5]\]. Moreover, Yao et al. have discovered that rs4886467, rs4558370, rs4461027, rs4886761, and rs16958477 SNPs located in the *LOXL1* gene promoter region are risk factors for XFS \[[@B6]\]. In addition, many other SNPs, such as rs429358 and rs7412 located on apolipoprotein E (*APOE*) \[[@B7]\], rs2107856 and rs2141388 of contactin-associated protein-like 2 (*CNTNAP2*) \[[@B8]\], rs41435250 and rs893818 of *LOXL1* \[[@B9]\], rs16958445 of TBC1 domain family member 21 (*TBC1D21*) \[[@B10]\], rs7137828 of autosomal-dominant ataxin 2 (*ATXN2*), rs35934224 of thioredoxin reductase 2 (*TXNRD2*), rs11732100 of actin filament-associated protein 1 (*AFAP1*), rs2472493 of ATP-binding cassette subfamily A member 1 (*ABCA1*), rs9897123 of growth arrest-specific 7 (*GAS7*) \[[@B11]\], rs4926244 of calcium voltage-gated channel subunit alpha1 A (*CACNA1A*) \[[@B12]\], and rs2279590 of clusterin (*CLU*) \[[@B13]\], have been associated with XFS/XFG. Accordingly, the aim of this study is to investigate whether these SNPs also affect XFS/XFG.

2. Materials and Methods {#sec2}
========================

2.1. Ethical Approval {#sec2.1}
---------------------

The Ethical Committee of the First Affiliated Hospital of Xinjiang Medical University, China, approved this study. In addition, the informed consent was obtained from all participants after explaining the objective and nature of the study. The study was conducted in accordance with the Declaration of Helsinki.

2.2. Study Population {#sec2.2}
---------------------

A total of 216 Uygur patients who were diagnosed as XFS/XFG and 297 normal Uygur volunteers who were admitted at the First Affiliated Hospital of Xinjiang Medical University, the First People\'s Hospital of Kashgar, and the Kuqa County Hospital between January 2015 and October 2017 were enrolled in this study. XFS was diagnosed based on the previously described approach \[[@B5]\]. In brief, XFS was diagnosed by exfoliation materials on the anterior lens capsule or on the pupil margin in either eye with dilation of the pupils. The inclusion criteria were the following: (1) IOP ≥22 mmHg in either eye; (2) glaucomatous changes on the optic disc, defined as a cup-to-disc ratio \>0.7 in either eye or an asymmetric cup-to-disc ratio \>0.2 or notching of the disc rim; and (3) characteristic glaucomatous visual field loss \[[@B14]\]. Patients with other causes of secondary glaucoma, such as uveitis, pigment dispersion syndrome, and iridocorneal endothelial syndrome, were excluded from the study. All study subjects were unrelated and received comprehensive ophthalmic examinations.

Peripheral blood samples (2-3 ml) were collected from each subject by venipuncture. Genomic deoxyribonucleic acid (DNA) was extracted from the whole blood using a Genomic DNA Extraction Kit (The Beijing Genomics Institute, Beijing, China). The SNPs (rs429358, rs7412, rs2107856, rs2141388, rs41435250, rs893818, rs16958445, rs7137828, rs35934224, rs11732100, rs2472493, rs9897123, rs4926244, and rs2279590) were amplified by photoconductive relay (PCR) and directly sequenced \[[@B7]--[@B13]\]. Two sets of primers were used for amplification by PCR.

Genotypes of these SNPs were determined by direct DNA sequencing, using a BigDye Terminator v3.1 Kit (Applied Biosystems, Foster City, CA) in a 3730XL capillary sequencer (Applied Biosystems). The sequences were analyzed by sequencing analysis software Chromas (Technelysium Pty Ltd., Queensland, Australia).

2.3. Statistical Analysis {#sec2.3}
-------------------------

Statistical analysis was performed using SPSS v17.0 software package (SPSS Inc., Chicago, IL). Hardy--Weinberg equilibrium (HWE) analysis was tested by using the *χ*^2^ test in SAS/Genetics v9.1 (SAS Institute Inc., Cary, NC, USA). The comparison of allelic and genotypic frequencies between the patient and control groups, as well as haplotype association analysis, was performed using a standard *χ*^2^ test. A *P* value \<0.05 was considered statistically significant. Relative risk association was estimated by calculating odds ratios (OR) along with 95% confidence intervals (CI).

3. Results {#sec3}
==========

A total of 216 Uygur XFS/XFG patients (case group) and 297 normal Uygur volunteers (control group) were included in the study. In the case group, there were 146 males and 70 females (average age: 68 years), while in the control group, there were 159 males and 138 females (average age: 62 year) ([Table 1](#tab1){ref-type="table"}).

All SNPs underwent the Hardy--Weinberg equilibrium test before further data analysis. Besides rs7137828 that deviated from HWE (*P*=0.006) in the control group and rs35934224 that deviated from HWE (*P*=0.005) in the case group, other SNPs were all in line with the HWE [Table 2](#tab2){ref-type="table"}.

The allele association analysis showed that the frequency of allele G of rs41435250 and rs893818 of *LOXL1* was significantly higher in XFS/XFG patients than in controls (rs41435250: *P* \< 0.001, OR = 1.791, 95% CI: 1.334--2.405; rs893818: *P* \< 0.001, OR = 0.423, 95% CI: 0.318--0.563), while no significant differences were found for other alleles (*P* \> 0.05) ([Table 3](#tab3){ref-type="table"}).

The genotype association analysis showed that the frequency of genotype AA for rs16958445 of *TBC1D21* was higher in XFS/XFG patients than in controls (*P*=0.033, OR = 5.481, 95% CI: 1.151--26.11), while the frequency of genotype GG was not significantly different between the two groups. After adjusting all data for age and gender, the following results were obtained: the frequency of genotype CC for rs7137828 of *ATXN2* was significantly higher in XFS/XFG patients than in controls (*P*=0.027, OR = 0.322, 95% CI: 0.118--0.879), while no significant differences were found with reference to the frequency of genotype TT. The frequency of genotype GG for rs893818 of *LOXL1* (*P* \< 0.001, OR* *= 0.511, 95% CI: 0.358--0.729) and the frequency of genotype AA were both significantly higher in the XFS/XFG group compared to the control group (*P* \< 0.001, OR* *= 0.095, 95% CI: 0.033--0.272). In addition, the frequency of genotype TT for rs41435250 of *LOXL1* was higher in XFS/XFG patients than in controls (*P*=0.003, OR* *= 3.902, 95% CI: 1.580--9.640), while no significant difference was found with reference to the frequency of genotype GG after adjusting for age and gender. All data are shown in [Table 4](#tab4){ref-type="table"}.

Moreover, our results indicated that all MAFs were greater than 0.05, which further suggested that all SNPs were statistically significant ([Table 5](#tab5){ref-type="table"}).

After the study of alleles and genotypes, we screened out the LOXL1, APOE, and CNTNAP2 for the haplotype association analysis. The genotyping graphs for these SNPs are shown in [Figure 1](#fig1){ref-type="fig"}.

For the rs41435250 and rs893818 of *LOXL1*, three haplotypes were observed. As shown in [Table 6](#tab6){ref-type="table"}, all haplotypes showed a significantly higher frequency in XFS/XFG patients than in controls: GA (*P* ≤ 0.001, OR* *= 0.417, 95% CI: 0.313--0.556), TG (*P* ≤ 0.001, OR* *= 1.772, 95% CI: 1.320--2.380), and GG (*P*=0.028, OR* *= 1.302, 95% CI: 1.030--1.648). Furthermore, after adjusting for age and gender, the similar data were obtained ([Table 7](#tab7){ref-type="table"}): GA (*P* ≤ 0.001, OR = 0.400, 95% CI: 0.286--0.559), TG (*P*=0.001, OR = 1.769, 95% CI: 1.251--2.503), and GG (*P*=0.029, OR = 1.356, 95% CI: 1.032--1.782). We also observed three haplotypes for rs429358 and rs7412 of *APOE* and rs2107856 and rs2141388 of *CNTNAP2*; nevertheless, there was no connection between the case and control group.

4. Discussion {#sec4}
=============

So far, numerous studies have focused on the polymorphisms of *LOXL1*. Our previous studies have shown that there were polymorphisms of *LOXL1* in different alleles and genotypes of different SNPs in XFS/XFG of different ethnic groups. In this study, we found two SNPs (rs41435250 and rs893818) of *LOXL1* that were polymorphic and associated with XFS/XFG. Meanwhile, we also examined other genes which were previously affirmed to have polymorphisms in XFS/XFG. We found that rs16958445 of *TBC1D21* and rs7137828 of *ATXN2* were significantly associated with XFS/XFG. Yet, three haplotypes for rs429358 and rs7412 of *APOE* and rs2107856 and rs2141388 of *CNTNAP2* had no connection between the case and control group.

As a result, *LOXL1* is still the susceptibility gene of XFS/XFG in Uygur populations. The rs1048661, rs3825942, rs2165241, rs4886467, rs4558370, rs4461027, rs4886761, rs16958477 \[[@B5], [@B6]\], and rs41435250 resulted to be risk factors, while rs893818 resulted to be a protective factor for XFS/XFG in the Uygur population.

Genes, such as *TBC1D21*, *ATXN2*, *APOE*, *CLU*, *AFAP1*, *TXNRD2*, *CACNA1A*, *ABCA1*, *GAS7*, and *CNTNAP2*, have been associated with glaucoma. In this study, we discovered that SNPs, rs16958445 of *TBC1D21* and the rs7137828 of *ATXN2*, had an important role in the pathogenesis of XFS/XFG in the Uygur population. Nonetheless, it is necessary to note that there may be other factors affecting the pathogenesis of XFS/G, which should be addressed by future studies.

In this research, we gathered a number of genes to study the polymorphisms of the special ethnic groups, thus providing valuable information and expanding the knowledge on the gene mechanism of XFS/XFG. Nonetheless, the current study has some limitations that should be pointed out. Although the patients were recruited from the three largest areas of Xinjiang, the sample representativeness may be somewhat inaccurate, which could be addressed by expanding the sample size and thus improving the accuracy. We found that multiple gene polymorphisms had an important role in the pathogenesis of the disorder in Uygur patients, but we cannot exclude the possibility that other additional genetic or environmental factors also participate in modifying the development of this disorder.
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###### 

Baseline of the two groups.

                           Case                       Control                     *t*     *P*
  ------------------------ -------------------------- --------------------------- ------- ---------
  Age (years), mean ± SD   68.90 ± 8.47               62.46 ± 9.94                9.13    \<0.001
  Gender (M/F), *n* (%)    146 (67.59%)/70 (32.41%)   159 (53.54%)/138 (46.45%)   10.25   \<0.001

M:male; F:female.

###### 

Hardy--Weinberg equilibrium test of these SNPs.

  GeneName   SNP          HWE_Case   HWE_Control   HWE
  ---------- ------------ ---------- ------------- -------
  LOXL1      rs893818     0.255      0.310         0.324
  LOXL1      rs41435250   0.497      1.000         0.505
  TBC1D21    rs16958445   0.111      0.555         0.553
  ATXN2      rs7137828    1.000      0.006         0.025
  CNTNAP2    rs2107856    1.000      1.000         1.000
  CNTNAP2    rs2141388    0.895      0.908         0.795
  APOE       rs429358     0.484      0.755         0.253
  APOE       rs7412       0.310      0.632         0.299
  CLU        rs2279590    0.367      1.000         0.490
  CACNA1A    rs4926244    0.074      0.616         0.099
  ABCA1      rs2472493    0.895      0.646         0.862
  GAS7       rs9897123    1.000      0.122         0.279
  AFAP1      rs11732100   0.692      0.482         0.793
  TXNRD2     rs35934224   0.005      1.000         0.101

Besides rs7137828 that deviated from the HWE in the control group and rs35934224 that deviated from the HWE in the case group, other SNPs were all in line with the HWE.

###### 

Allele association analysis with these SNPs.

  SNP          XFS/XFG   Control   *χ* ^2^   *P*       OR (95% CI)
  ------------ --------- --------- --------- --------- -----------------------
  TBC1D21                                               
  rs16958445                                            
  Allele                                                
  G            432       583       3.025     0.082     1.369 (0.960--1.953)
  A            70        69                            
                                                       
  ATXN2                                                 
  rs7137828                                             
  Allele                                                
  T            429       531       3.272     0.070     0.7467 (0.544--1.025)
  C            73        121                           
                                                       
  APOE                                                  
  rs429358                                              
  Allele                                                
  T            452       587                            
  C            50        65        \<0.001   0.996     0.999 (0.677--1.473)
                                                       
  rs7412                                                
  Allele                                                
  C            468       610                            
  T            34        42        0.051     0.822     1.055 (0.661--1.685)
                                                       
  CLU                                                   
  rs2279590                                             
  Allele                                                
  C            351       455                            
  T            151       197       0.002     0.961     0.994 (0.771--1.280)
                                                       
  AFAP1                                                 
  rs11732100                                            
  Allele                                                
  C            402       524                            
  T            100       128       0.015     0.903     1.018 (0.760--1.364)
                                                       
  TXNRD2                                                
  rs35934224                                            
  Allele                                                
  C            446       574                            
  T            56        78        0.180     0.671     0.924 (0.642--1.331)
                                                       
  CACNA1A                                               
  rs4926244                                             
  Allele                                                
  T            401       515                            
  C            101       137       0.138     0.710     0.947 (0.710--1.263)
                                                       
  ABCA1                                                 
  rs2472493                                             
  Allele                                                
  A            301       391                            
  G            201       261       \<0.001   0.998     1.000 (0.789--1.269)
                                                       
  LOXL1                                                 
  rs41435250                                            
  Allele                                                
  G            379       552                            
  T            123       100       15.280    \<0.001   1.791 (1.334--2.405)
                                                       
  rs893818                                              
  Allele                                                
  G            418       442                            
  A            84        210       35.780    \<0.001   0.423 (0.318--0.563)
                                                       
  GAS7                                                  
  rs9897123                                             
  Allele                                                
  C            249       341                            
  T            253       311       0.827     0.363     1.114 (0.883--1.406)
                                                       
  CNTNAP2                                               
  rs2107856                                             
  Allele                                                
  G            299       390                            
  T            203       262       0.008     0.930     1.011 (0.797--1.281)
                                                       
  rs2141388                                             
  Allele                                                
  C            301       391                            
  T            201       261       \<0.001   0.998     1.000 (0.789--1.269)

G allele of rs41435250 of LOXL1 was the risk allele for the disorder. In contrast, G allele of rs893818 of LOXL1 was the protective allele for the disorder. Other alleles of SNPs showed no statistical significance.

###### 

Genotype association analysis with these SNPs.

  Gene/SNP     XFS/XFG   Control   p         OR (95% CI)             Adjusted-P   Adjusted-OR (95% CI)
  ------------ --------- --------- --------- ----------------------- ------------ -----------------------
  TBC1D21                                                                          
  rs16958445                                                                       
  Genotype                                                                         
  GG           189       259       0.532     1.138 (0.758--1.71)     0.114        1.465 (0.913--2.351)
  GA           54        65        0.033     5.481 (1.151--26.110)   0.043        5.439 (1.053--28.090)
  AA           8         2                                                        
                                                                                  
  ATXN2                                                                            
  rs7137828                                                                        
  Genotype                                                                         
  TT           183       224       0.705     0.929 (0.635--1.360)    0.955        1.013 (0.654--1.569)
  TC           63        83        0.027     0.322 (0.118--0.879)    0.030        0.299 (0.100--0.891)
  CC           5         19                                                       
                                                                                  
  APOE                                                                             
  rs429358                                                                         
  Genotype                                                                         
  TT           202       263       0.910     1.025 (0.673--1.560)    0.532        1.171 (0.714--1.920)
  TC           48        61        0.727     0.651 (0.059--7.230)    0.773        0.697 (0.060--8.091)
  CC           1         2                                                        
                                                                                  
  rs7412                                                                           
  Genotype                                                                         
  CC           219       286       0.907     1.031 (0.619--1.717)    0.873        1.049 (0.585--1.882)
  CT           30        38        0.790     1.306 (0.183--9.344)    0.887        1.172 (0.132--10.400)
  TT           2         2                                                        
                                                                                  
  CLU                                                                              
  rs2279590                                                                        
  Genotype                                                                         
  CC           126       159       0.604     0.912 (0.644--1.292)    0.298        0.807 (0.538--1.209)
  CT           99        137       0.760     1.094 (0.616--1.943)    0.171        1.586 (0.819--3.071)
  TT           26        30                                                       
                                                                                  
  AFAP1                                                                            
  rs11732100                                                                       
  Genotype                                                                         
  CC           162       208       0.678     0.927 (0.649--1.324)    0.922        0.979 (0.650--1.477)
  CT           78        108       0.442     1.412 (0.585--3.407)    0.576        0.711 (0.215--2.350)
  TT           11        10                                                       
                                                                                  
  TXNRD2                                                                           
  rs35934224                                                                       
  Genotype                                                                         
  CC           203       252       0.118     0.709 (0.461--1.091)    0.175        0.710 (0.433--1.165)
  CT           40        70        0.142     2.483 (0.737--8.362)    0.258        2.245 (0.553--9.114)
  TT           8         4                                                        
                                                                                  
  CACNA1A                                                                          
  rs4926244                                                                        
  Genotype                                                                         
  TT           165       205       0.349     0.840 (0.584--1.209)    0.224        0.774 (0.512--1.170)
  TC           71        105       0.684     1.165 (0.559--2.426)    0.826        0.901 (0.356--2.282)
  CC           15        16                                                       
                                                                                  
  ABCA1                                                                            
  rs2472493                                                                        
  Genotype                                                                         
  AA           91        115       0.713     0.934 (0.650--1.343)    0.831        0.955 (0.626--1.457)
  AG           119       161       0.888     1.036 (0.631--1.702)    0.906        0.966 (0.544--1.716)
  GG           41        50                                                       
                                                                                  
  LOXL1                                                                            
  rs41435250                                                                       
  Genotype                                                                         
  GG           145       233       0.006     1.663 (1.158--2.388)    0.071        1.478 (0.966--2.259)
  GT           89        86        0.003     3.902 (1.580--9.640)    0.003        5.276 (1.748--15.930)
  TT           17        7                                                        
                                                                                  
  rs893818                                                                         
  Genotype                                                                         
  GG           171       154       \<0.001   0.511 (0.358--0.729)    \<0.001      0.4449 (0.293--0.676)
  GA           76        134       \<0.001   0.095 (0.033--0.272)    \<0.001      0.119 (0.039--0.356)
  AA           4         38                                                       
                                                                                  
  GAS7                                                                             
  rs9897123                                                                        
  Genotype                                                                         
  CC           62        82        0.739     0.934 (0.625--1.396)    0.440        0.833 (0.523--1.325)
  CT           125       177       0.335     1.263 (0.785--2.033)    0.808        0.935 (0.542--1.612)
  TT           64        67                                                       
                                                                                  
  CNTNAP2                                                                          
  rs2107856                                                                        
  Genotype                                                                         
  GG           89        117       0.917     1.02 (0.709--1.467)     0.687        1.091 (0.715--1.665)
  GT           121       156       0.947     1.017 (0.622--1.664)    0.537        1.194 (0.681--2.094)
  TT           41        53                                                       
                                                                                  
  rs2141388                                                                        
  Genotype                                                                         
  CC           91        118       0.981     0.996 (0.692--1.431)    0.772        1.064 (0.698--1.624)
  CT           119       155       0.990     1.003 (0.614--1.639)    0.570        1.177 (0.672--2.060)
  TT           41        53                                                       

The genotypes AA for rs16958445 of TBC1D21 and GG/TT for rs41435250 of LOXL1 were risk genotypes for the disease. The genotypes CC for rs7137828 of ATXN2 and GG/AA for rs893818 of LOXL1 were protective genotypes for the disease.

###### 

MAFs of these SNPs.

  Gene      SNP          Ref allele   Alt allele   Case MAF   Control MAF   Total MAF
  --------- ------------ ------------ ------------ ---------- ------------- -----------
  LOXL1     rs893818     G            A            0.167      0.322         0.255
  LOXL1     rs41435250   G            T            0.245      0.153         0.193
  TBC1D21   rs16958445   G            A            0.139      0.106         0.121
  ATXN2     rs7137828    T            C            0.145      0.186         0.168
  CNTNAP2   rs2107856    G            T            0.404      0.402         0.403
  CNTNAP2   rs2141388    C            T            0.400      0.400         0.400
  APOE      rs429358     T            C            0.100      0.100         0.100
  APOE      rs7412       C            T            0.068      0.064         0.066
  CLU       rs2279590    C            T            0.301      0.302         0.302
  CACNA1A   rs4926244    T            C            0.201      0.210         0.206
  ABCA1     rs2472493    A            G            0.400      0.400         0.400
  GAS7      rs9897123    C            T            0.496      0.477         0.489
  AFAP1     rs11732100   C            T            0.199      0.196         0.198
  TXNRD2    rs35934224   C            T            0.112      0.120         0.116

All MAFs were greater than 0.05, which pointed out that all these SNPs were statistically significant.

###### 

Haplotype association analysis between these SNPs.

  Gene      Haplotype    Case (proportion)   Control (proportion)   *P* value     OR       95% CI         
  --------- ------------ ------------------- ---------------------- ------------- -------- -------------- --------------
            rs41435250   rs893818                                                                          
  LOXL1     G            A                   83 (0.165)             210 (0.322)   ≤0.001   0.417          0.313--0.556
  T         G            122 (0.243)         100 (0.153)            ≤0.001        1.772    1.320--2.380   
  G         G            296 (0.590)         342 (0.525)            0.028         1.302    1.030--1.648   
                                                                                                          
            rs429358     rs7412                                                                            
  APOE      T            C                   418 (0.833)            545 (0.836)   0.884    0.977          0.715--1.336
  C         C            50 (0.100)          65 (0.100)             0.996         0.999    0.677--1.473   
  C         T            34 (0.068)          42 (0.064)             0.822         1.055    0.661--1.685   
                                                                                                          
            rs2107856    rs2141388                                                                         
  CNTNAP2   T            T                   201 (0.400)            261 (0.400)   0.998    1.000          0.789--1.269
  G         C            299 (0.596)         390 (0.598)            0.930         0.990    0.781--1.254   

The haplotypes GG/TG/GA for the SNPs rs41435250 and rs893818 were significantly associated with XFS/XFG.

###### 

Haplotype (adjusted) association analysis between these SNPs.

  Gene      Haplotype    Case (proportion)   Control (proportion)   *P* value     OR       95% CI         
  --------- ------------ ------------------- ---------------------- ------------- -------- -------------- --------------
            rs41435250   rs893818                                                                          
  LOXL1     G            A                   67 (0.155)             189 (0.319)   ≤0.001   0.400          0.286--0.559
  T         G            101 (0.234)         89 (0.150)             0.001         1.769    1.251--2.503   
  G         G            264 (0.611)         314 (0.530)            0.029         1.356    1.032--1.782   
                                                                                                          
            rs429358     rs7412                                                                            
  APOE      T            C                   360 (0.833)            494 (0.834)   0.609    0.910          0.634--1.307
  C         C            42 (0.097)          57 (0.096)             0.643         1.113    0.707--1.753   
  C         T            30 (0.069)          41 (0.069)             0.834         1.059    0.621--1.806   
                                                                                                          
            rs2107856    rs2141388                                                                         
  CNTNAP2   T            T                   180 (0.417)            239 (0.404)   0.569    1.083          0.823--1.424
  G         C            250 (0.579)         352 (0.595)            0.523         0.915    0.696--1.202   

The haplotypes GG/TG/GA for the SNPs rs41435250 and rs893818 were significantly associated with XFS/XFG.

[^1]: Academic Editor: Ozlem G. Koz
